Antidepressant Effexor XR is being recalled because they may contain capsules of Tikosyn (dofetilide), which is used to treat heart rhythm disorders. The recall comes after a pharmacist found that a bottle of Effexor XR contained one capsule of Tikosyn 0.25 milligram.
Unknowingly taking Tikosyn could be fatal.
The recall is for:
one lot of Pfizer's 30-count Effexor XR 150-milligram extended-release capsules and one lot of 90-count Effexor XR 150-milligram extended-release capsules of drug lot numbers V130142 and V130140 that have an expiration date of October 2015
lot number V130014 of 90-count Greenstone venlafaxine HC1 150-milligram extended-release capsules, which has an expiration date of August 2015
The U.S. Food and Drug Administration advises pharmacists to immediately stop sales of the recalled lots of the drugs and notify customers who have been sold the drugs. Recalled medicines should be returned to their pharmacy and patients with the said medicines should contact their doctor.
Pfizer said that patients prescribed Effexor XR/Venlafaxine HCl who may have mistakenly taken a Tikosyn capsule should contact their doctor or a hospital immediately ,monitor themselves for signs of abnormal heartbeat, and seek medical help if they feel faint, become dizzy, or have a fast heartbeat.
For additional recall information, consumers may call Pfizer at 1-800-438-1985, Monday to Thursday 9 a.m. to 8 p.m. ET or Friday from 9 a.m. to 5 p.m. ET.